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Abstract
Alpha-tocopherol transfer protein (α-TTP) is a liver cytosolic transport protein that faciliates α-tocopherol (α-T) transfer into liver secreted plasma
lipoproteins. Genetic defects in α-TTP, like dietary vitamin E deficiency, are associated with infertility, muscular weakness and neurological disorders.
Both human and α-TTP deficient (α-TTP
-/-) mice exhibit severe plasma and tissue vitamin E deficiency that can be attenuated by sufficient dietary
α-T supplementations. In this review, we summarize the literature concerning studies utilizing the α-TTP
-/- mice. Levels of vitamin E in the α-TTP
-/-
mice do not appear to be directly related to the amounts of dietary α-T or to the levels of α-TTP protein in tissues. The α-TTP
-/-  mice appear
to present a good model for investigating the specific role of α-T in tissue vitamin E metabolism. Furthermore, α-TTP
-/- mice appear to be useful
to elucidate functions of α-TTP beyond its well recognized functions of transferring α-T from liver to plasma lipoprotein fractions.
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Introduction1)
Vitamin E is a generic term which describes a group of 
lipophilic chain breaking antioxidants in biological membranes 
and includes 4 tocopherols (α-, β-, γ- and δ-) and 4 tocotrienols 
(α-, β-, γ- and δ-) (Traber, 1999). Vitamin E plays an important 
role in reproduction and in maintaining the structural integrity 
of the cells (Evans & Bishop, 1922; Packer, 1991). α-tocopherol 
(α-T) is the dominant isoform found in human and animals. 
Indeed, in the 2000 Dietary Reference Intakes, only α-T was 
recommended as meeting human dietary vitamin E requirements 
(Food and Nutrition Board & Institute of Medicine, 2000). α-T 
functions additionally beyond its well recognized antioxidant role 
of smooth muscle cells. For example, α-T inhibits proliferation 
via a protein kinase C-dependent mechanism (Boscoboinik et al., 
1991a; Boscoboinik et al., 1991b; Ricciarelli et al., 1998). 
However,  α-T functions in most tissues remain to be fully 
clarified.
In humans, α-T deficiency occurs as a result of genetic defects 
in the hepatic α-tocopherol transfer protein (α-TTP) and causes 
a rare neurological disease, ataxia with vitamin E deficiency 
(AVED) (Ouahchi et al., 1995). Subsequently, α-TTP knock out 
(α-TTP
-/-) mice were shown to exhibit many of the same 
phenotypes as humans with AVED (Yokota et al., 2001). In the 
human disease the neurologic abnormalities are a result of the 
α-T deficiency as neurologic manifestations can be ameliorated 
by a greatly augmented oral vitamin E intake. However, α-TTP 
functions remain to be completely clarified, especially in the few 
non-hepatic tissues where it has been detected. Although α-T 
enrichment of plasma is mediated by liver α-TTP, the α-TTP 
protein may also modulate tissue α-T levels (Arita et al., 1995; 
Traber & Arai, 1999). The molecular mechanisms of how α-T 
levels are regulated in different tissues and the extent to which 
α-TTP interrelate to these mechanisms, likewise remains 
incompletely understood. The following review will provide a 
summary of general characteristics and gene profiles of α-TTP
-/- 
mice, and regulation of plasma and tissue levels of α-T 
manipulated by dietary α-T in α-TTP
-/- mice.
α-T transfer protein 
α-TTP is a 32 kDa cytosolic lipid binding protein known as 
a member of the cis-retinal binding motif sequence (CRAL- TRIO) 
protein family (Panagabko et al., 2003). α-TTP was first described 
in 1975 by Catignani et al. (1975) as a hepatic α-T binding protein. 
α-TTP is expressed primarily in liver, but has been detected in 
various tissues including lung, spleen, kidney, brain, adrenals, 
uterus (pregnant rodent) and placenta (Copp et al., 1999; Gohil 
et al., 2004; Hosomi et al., 1998; Jishage et al., 2001; 
Kaempf-Rotzoll et al., 2003; Kaempf-Rotzoll et al., 2002). 
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All forms of dietary vitamin E are absorbed and transported 
via chylomicrons through lymph into the circulation (Arita et 
al., 1995). Unlike non-specific absorption of vitamin E, α-TTP 
mediates the selective transport of α-T in its RRR- or 2R- forms 
into nascent very low density lipoproteins (VLDL) and is 
responsible for secretion of α-T from the liver into blood to 
maintain plasma α-T concentrations (Arita et al., 1995). 
Liver  α-TTP has been isolated and its cDNA sequences 
reported from a variety of species. The human gene has been 
localized to the 8q13.1-13.3 region of chromosome 8 (Arita et 
al., 1995; Doerflinger et al., 1995). α-TTP has been crystallized 
and the α-T binding pocket identified (Meier et al., 2003; Min 
et al., 2003). α-TTP has a hinge and a cover that closes 
entrapping  α-T in the binding pocket that causes α-T to fold 
such that the 2-position is critical for its fit (Meier et al., 2003; 
Min et al., 2003). 
α-TTP has ligand specificity and relative affinities towards 
different tocopherols (α-> β-> γ-> δ-T) in vitro (Hosomi et al., 
1997). Tocopherol binding affinity and transfer activity of α-TTP 
and ligand selectivity discriminating physiological factor for α-T 
retention were also demonstrated in vitro models (Morley et al., 
2004; Panagabko et al., 2003; Panagabko et al., 2002). However, 
binding affinity of α-TTP to α-T and roles of α-TTP beyond 
incorporation of α-T to very low density lipoproteins (VLDL) 
were not demonstrated in various tissues from in vivo models.
A recent study has shown that high concentration of hepatic 
α-tocopherol caused by high α-T injection increased hepatic α-T 
concentrations but didn’t induce either hepatic α-TTP mRNA and 
protein levels in rats (Mustacich et al., 2006). The result suggests 
that hepatic α-T levels doesn’t regulate α-TTP gene expression. 
To elucidate the importance of vitamin E in vivo, α-TTP gene 
deletion leading to vitamin E deficiency was required due to 
difficulty of dietary depletion of vitamin E in humans and animals 
(Cuddihy et al., 2004). α-TTP
-/- mice were generated by targeted 
disruption of α-TTP (Jishage et al., 2001; Terasawa et al., 2000). 
Infertility in females with α-T deficiency
Vitamin E was first recognized as a “reproductive factor” in 
1922 by Evans and Bishop (Evans and Bishop, 1922). Impaired 
fertility, such as resorption of the fetus, was reported in female 
α-TTP
-/-  mice (Jishage et al., 2001; Terasawa et al., 2000) while 
no signs of male infertility were detected (Terasawa et al., 2000). 
In pregnant α-TTP
-/- mice, placental failure was effectively 
abrogated by dietary α-T (567 mg/kg diet) or a synthetic 
antioxidant (BO-653) (Jishage et al., 2001). Female rats with 
vitamin E deficiency demonstrated structural changes of ovary 
and uterus and abnormal estrus cycle (Das and Chowdhury, 
1999).  α-T levels increased in the placental membrane as 
gestation progressed during feto-placental development in normal 
humans and rodents (Jishage et al., 2001; Qanungo et al., 1999; 
Sen & Mukherjea, 1998). Moreover, α-TTP was not expressed 
in the placenta but in the uterus to supply α-T for placenta and 
fetus during the development of placental labyrinthine tropoblasts 
in mice (Jishage et al., 2001). These results suggest that α-TTP 
is a critical fertility factor to provide enough α-T for the 
maintenance of a regular estrous cycle and protection of placenta 
and fetus during pregnancy. It should be noted that mice and 
humans have very different placental structures and that α-TTP 
has been detected in human placenta (Muller-Schmehl et al., 
2004).
Neurological disorders in α-T deficiency
Vitamin E deficiency is associated with neurological abnor-
malities in humans and animals suggesting α-T’s importance in 
the central nervous systems. The α-TTP mRNA expression was 
demonstrated in cerebral cortex, especially Purkinje cells and in 
cerebellum (Hosomi et al., 1998) possibly to protect the brain 
from oxidative stress by providing α-T (Meier et al., 2003). 
AVED patients with genetic defects of α-TTP had very low or 
undetectable plasma α-T levels and progressive spinocerebellar 
dysfunctions (Hoshino et al., 1999; Hosomi et al., 1998; Ouahchi 
et al., 1995; Yokota et al., 1997; Yokota et al., 2000). 
Although specific discrimination of α-T by α-TTP was shown 
in in vitro models (Hosomi et al., 1997; Panagabko et al., 2003; 
Panagabko et al., 2002) some human α-TTP mutants showed 
α-T transfer activity similar to that of wild type protein 
suggesting that α-TTP may have additional physiological 
functions in vivo (Morley et al., 2004). Therefore, we should 
consider the importance of an in vivo animal model to investigate 
effects of α-T in AVED and other possible genetic disorders in 
inbreeding mice as well. 
Gene profiles related to neurodegeneration
α-TTP
-/- mice showed many features of neurological diseases 
as seen in humans with AVED. Specifically, the mice with ataxia 
had very low plasma and brain α-T levels (Yokota et al., 2001). 
Gene profile studies in α-TTP
-/- cortex identified putative genes 
affected by genetic deletion of α-TTP and may account for 
neurological disorders (Gohil et al., 2004; Gohil et al., 2003). 
These studies showed down-regulation in α-TTP
-/- cortex of genes 
related to neurogenesis and increased expression of genes related 
to neurodegeneration. The authors suggested that some of the 
affected genes may be regulated by retinoic acid receptor related 
orphan receptor α. In female α-TTP
-/- cerebral cortex, selective 
genes, such as myelin associated oligodendrocyte specific protein 
and proteolipid protein, associated with synaptogenesis and 
myelination were repressed. Induction of neurodegenerative 
genes, such as synulein-α, repression of synulein-β and induction 
of mitochondrial proapoptotic factor, cytochrome c, were also 
shown in α-TTP
-/- cerebral cortex (Gohil et al., 2004; Gohil et 
al., 2003). Although apparent neurological signs were not 
reported in 3-4 months old mice (Gohil et al., 2003; Jishage 
et al., 2001; Terasawa et al., 2000; Yokota et al., 2001), Yunsook Lim and Maret G. Traber 249
Table 1. Relationship of plasma (μmol/l) and tissue α-T (nmol/g) and dietary α-T in α-TTP -/- mice
Dietary
α-T
(mg/kg)
Feeding
Period
(wks)
Plasma (μmol/l)
Tissue α-T concentrations (nmol/g)
Reference. Liver Lung Heart Cortex Cerebellum
TTP+/+ TTP-/- TTP+/+ TTP-/- TTP+/+ TTP-/- TTP+/+ TTP-/- TTP+/+ TTP-/- TTP+/+ TTP-/-
99 27 ~7 <0.1 ~58 ~20 ~28 ~2 ~30 ~3.5 ~30** <0.1** - - (Terasawa 
et al., 2000)
0
43
~0.9 <0.5 - - - - ~0.9 <0.2 ~1.2 <0.2 ~1.6 <0.2
(Yokota et 
al., 2001)
36 ~4.4 - - - - - ~25.5 - ~26.7 - ~13.5 -
600 - ~3.5 - - - - - ~20.9 - ~1.8 - ~2.6
3 6 8 9 . 3 < 0 . 1 --- - ------ ( J i s h a g e  et 
al., 2001) 6 0 0 1 6 . 3 4 . 7 --- - ------
60* 12 21.3±0.5 1.2±0.3 122.4±6.4 47.7±17.7 62.9±3.7 6.1±2.1 74.1±2.5 6.1±1.5 48.3±3.1** 0.9±0.1** - - (Leonard et 
al., 2002)
35 11-15 4.5±0.8 0.3±0.0 13.0±4.0 6.1±2.2 - - - - 24.0±2.5 0.3±0.1 - - (Gohil et al., 
2003)
66 ~14 4.3±0.6 0.3±0.1 25.9±3.3 8.8±0.9 21.1±2.6 2.3±0.3 - - - - - - (Schock et 
al., 2004)
0 5 0.5±0.1 0.1±0.1 1.0±0.5 0.2±0.2 2.0±0.8 0.5±0.1 1.3±0.3 0.7±0.1 3.4±0.6 0.1±0.4 3.7±1.2 1.1±0.1 (Schock et 
al., 2004) 35 4.4±0.8 0.4±0.1 13.1±3.2 6.0±1.6 13.8±3.3 1.4±0.3 16.0±4.5 1.9±0.5 8.8±2.1 0.7±0.1 6.6±0.8 3.4±0.6
*  30mg  d6-RRR-α-tocopherol  and  30  mg  d3  all  rac-α-tocopherol  per  kg  high  polyunsaturated  fat  diet
**  whole  brain
neurological behaviors such as balance, coordination, strength, 
exploratory behavior and anxiety were affected in α-TTP
-/- mice 
fed a α-T deficient or a normal diet up to at age of 6 months 
(Gohil et al., 2003; Jishage et al., 2001; Terasawa et al., 2000; 
Yokota et al., 2001). Learning and memory skills were 
significantly decreased in old female α-TTP
-/- mice at age of 12 
months old (Gohil et al., 2004). However, by the age of 18 
months  α-TTP
-/- mice fed normal α-T diets developed abnor-
malities gradually while those fed deficient diets had obvious 
ataxia (Yokota et al., 2001). These differences in response along 
with the slow progression of abnormalities might be due to 
different dietary α-T concentrations and/or the duration of 
feeding, as well as different genetic backgrounds, ages and 
genders of mice (Table 1). The results suggest that the 
combination of genetic α-TTP defect (or deficiency) and dietary 
α-T deficiency would exacerbate neurodegeneration caused by 
prolonged α-T deficiency. The neurological abnormalities were 
prevented or attenuated when high dietary α-T was supplemented 
to  α-TTP
-/- mice, as well as to patients with AVED (Mariotti 
et al., 2004; Schuelke et al., 2000; Yokota et al., 2001; Yokota 
et al., 1997). Recent studies in phospholipid transfer protein 
(PLTP) deficient mice having brain α-T concentrations at higher 
levels than in apparently normal α-TTP -/-mice demonstrated 
vitamin E deficiency-related anxiety but did not show any 
evidence of neurological disorders, including neuromotor 
coordination (Desrumaux et al., 2005). It is likely that there will 
be tissue specific responses that are also dependent on α-T 
concentrations in various brain region .
Gene profiles related to vasculogenesis, signal transduction 
pathways and cell proliferation 
The gene profile studies also suggested that deletion of α-TTP 
leading to α-T deficiency causes tissue specific change of genes 
associated with vasculogenesis, signal transduction pathways and 
cell proliferation (Gohil et al., 2003; Vasu et al., 2007). In α
-TTP
-/- liver, changes in genes associated with neovascularization 
including quaking, NMDA receptor regulated gene 1 and 
hyalurinidase I were found. In addition, cell proliferation 
pathways such as growth factor binding proteins, mitogen 
activated protein kinase kinase 3 and apoptosis inhibitor 6 were 
activated in α-TTP
-/- liver (Gohil et al., 2003). Moreover, genes 
related to signal transduction such as casein kinase 1, dou-
blecortin and calcium/calmodulin-dependent protein kinase-like 
1 were downregulated in heart gene profile study of α-TTP
-/- 
mice (Vasu et al., 2007). 
Taken together, the gene profile studies demonstrated that α
-TTP
-/- mice are a useful model to find target genes related to 
neurological disorders or neurodegeneration which could be 
prevented or attenuated by dietary vitamin E treatment and 
vasculogenesis, signal transduction pathways and cell prolifera-
tion. Further gene profile studies identifying gender differences 
in different feeding regimen (time and dose) at different age and 
verifying reversibility of the neurological symptoms are recom-
mended for future application of dietary α-T in patients with 
AVED.
Oxidative stress, inflammatory and immune response related 
markers
Vitamin E is a widely accepted antioxidant and a potent 
anti-inflammatory agent. α-TTP mRNA level was decreased in 
rat liver exposed to hypoxia (Ban et al., 2002). α-TTP deletion 
increased levels of lipid peroxidation measured by thiobarbituric 
acid reactive substances (TBARS) and 4-hydroxy-2-nonenal 
(HNE) in brain and by malondialdehydes in plasma (Terasawa 250 Alpha-tocopherol transfer protein (α-TTP)
et al., 2000; Yokota et al., 2001). α-TTP deletion with vitamin 
E deficiency increased another lipid peroxidation biomarkers 
demonstrated by 8-iso-prostaglandin F2α (8-iso-PGF2α) and 
hydroxyoctadecadienoic acid (tHODE) in retina and retinal 
pigment epithelium (RPE) fraction (Tanito et al., 2007). Moreo-
ver, F2-isoprostanes levels in aortic lesions were increased in α
-TTP
-/-ApoE
-/- mice, which are atherosclerosis susceptible and 
vitamin E deficient, when compared to that of α-TTP 
+/+ApoE
-/- 
mice (Terasawa et al., 2000). α-TTP
-/- mice challenged with 
lipopolysaccharide affected the inflammatory markers including 
heme oxygenase -1, inducible nitric oxide synthetase expression 
and nitric oxides (NOx) release in lung and liver (Schock et al., 
2004). 
Additionally, protein oxidation (protein carbonyl) in lung 
lavage fluid, lung and liver and protein kinase C activity were 
increased in polymorphonuclear cells of α-TTP
-/- mice. However, 
levels of vitamin C and urate in lung tissues remained unchanged 
in  α-TTP
-/- mice (unpublished data). 
As a supportive evidence, genes regulated by antioxidant 
response elements such as metallothionein II and glutathione- 
s-transferase  π  were selectively induced in α-TTP
-/- liver. 
However, classical antioxidant enzymes such as catalase, 
gluthathione peroxidase, and superoxide dismutase were not 
induced in α-TTP
-/- liver, lung and heart (Gohil et al., 2003; 
Oommen et al., 2007; Vasu et al., 2007). It was similar patterns 
shown in lung tissues of α-TTP
+/+ mice fed an vitamin E deficient 
diet (Gohil et al., 2004) as shown in the lung tissues of α-TTP
-/- 
mice (Gohil et al., 2007). Interestingly, genes involved in 
detoxification of xenobiotics (cytochrome p450 1a2 and 2d9) 
were induced in α-TTP
-/- liver and herat (Gohil et al., 2003; Vasu 
et al., 2007). 
Vit E has been known as a regulator of immune functions 
and vit E deficiency modulates immune responses (Beharka et 
al., 1997). The immunoglobulin genes including immunoglobulin 
kappa chain variable 8, immunoglobulin joining chain, imm-
unoglobulin heavy chain, complement factor D were down-
regulated (Vasu et al., 2007). 
These results suggest that α-TTP may play a role in modulation 
of inflammatory-immune responses and antioxidant systems. 
Moreover, α-TTP
-/-  mice are mildly susceptible to oxidative stress 
and might use other indirect antioxidant defense systems instead 
of classical antioxidant defense mechanism. Therefore, α-TTP
-/- 
mice are a practical model to discriminate antioxidant and 
anti-inflammatory functions α-T and to identify biomarkers of 
oxidative stress
  and inflammation in various disease states. 
The relationship between dietary α-T and plasma or tissue α-T 
α-TTP is the primary determinant of plasma α- T levels (Gohil 
et al., 2003; Jishage et al., 2001; Leonard et al., 2002; Schock 
et al., 2004; Terasawa et al., 2000; Yokota et al., 2001). Plasma 
and tissue α-T levels were very low in α-TTP
-/- mice fed α-T 
deficient or normal diets but with vitamin E supplementation 
concentrations were comparable to those of wild-type mice fed 
normal diets (Table 1). During chylomicron catabolism vitamin 
E is transported to other lipoproteins bypassing the sorting 
function of α-TTP in the liver (Traber et al., 1990). If vitamin 
E intakes are sufficiently high, then α-TTP is not necessary to 
maintain plasma α-T concentrations. 
Liver  α-T levels in α-TTP
-/- mice were 34-47% of those of 
wild-type mice when fed normal diets (30-150 mg/kg) (Table 
1). Brain α-T concentrations in α-TTP
-/- mice were less than 10% 
of those of wild-type mice fed normal diets (Traber et al., 2005). 
In long term (38 weeks) vitamin E deficient wild-type mice, the 
brain retained approximately 50% of its α-T while liver was 
approximately 95% deficient (Cuddihy et al., 2004; Traber et 
al., 2005). Interestingly, liver α-T in α-TTP
-/- mice on normal 
diets was relatively well-maintained compared to wild-type mice 
with dietary vitamin E deficiency. This might be due to 
non-specific transport of α-T from gut to liver. Our group 
reported that α-T modulates cytochrome p 450 system especially, 
cyp3a, which is responsible for xenobiotic metabolism and is 
regulated by pregnane X receptor (Goodwin et al., 2002; Traber 
et al., 2005). This regulatory role of α-T in metabolizing toxic 
substances may be the reason that the liver maintains relatively 
high  α-T levels compared to other organs. The results also 
suggest that α-TTP
-/- mice are more susceptible to neurological 
disorders because brain α-T levels are lower in α-TTP
-/- mice 
compared to dietary vitamin E deficient wild-type mice.
Lung, spleen, kidney and heart α-T levels in α-TTP
-/- mice 
were very low (only 10-15%) compared with those of wild-type 
mice fed normal diets (Leonard et al., 2002; Traber et al., 2005). 
In chow (vitamin E, ~99 mg/kg)-fed mice for 27 weeks, α-T 
levels of α-TTP
-/- liver, adipose tissue, adrenal gland and aorta 
were 15-35% of those of wild type mice (Terasawa et al., 2000). 
α-T levels were undetectable in the plasma (<0.46 μmol/l) and 
tissues (<0.2 nmol/g) of α-TTP
-/- m ice w hen fed α-T deficient 
diet for ~43 weeks. After α-T supplementation  (600 mg/kg diet), 
α-T levels in α-TTP
-/- mice increased to 70-90% of wild-type 
levels in the plasma (~3.5 μmol/l) and heart (~21 nmol/g) but 
were slightly increased in the cerebrum cortex (6.8%), cerebellum 
(19.6%), and spinal cord (23.8%) as compared to those of wild 
type mice fed normal diets (Yokota et al., 2001). Another study 
showed selective transport of RRR- or 2R- α-T from 1:1 mixture 
of natural and synthetic α-T by α-TTP and relatively higher 
plasma and tissue α-T levels compared to those of other studies 
in both α-TTP
-/- and wild-type mice; these latter diets were high 
in polyunsaturated fat (Leonard et al., 2002). 
Our group also demonstrated tissue specific gene expression 
profiles in 5 different tissues including liver, lung, brain, adrenal 
and spleen of α-TTP
-/- mice (Gohil et al., 2004). The number 
of genes which are sensitive to α-TTP in tissues was not 
correlated with levels of α-T in the same tissues. Additionally, 
the levels of α-TTP expressed in tissues are not directly 
correlated with the levels of α-T (unpublished data). Each tissue 
might specifically preserve α-T for its own functions i.e. spleen Yunsook Lim and Maret G. Traber 251
and thymus for immune functions, plasma and liver for 
maintenance of homeostasis and lung and skin for protection 
from environmental insults such as ozone. In the plasma, the 
distribution of α-T to tissues is related to plasma levels of low 
density lipoprotein (LDL) and high density lipoprotein (HDL) 
which deliver α-T to tissues (Traber et al., 1992). Thus, α-T 
levels in plasma are dependent on plasma concentrations of these 
lipoproteins (Mardones et al., 2002). Scavenger receptor class 
B1 type (SR-B1) binds HDL, then mediates selective lipid uptake 
from HDL (Trigatti et al., 2000). SR-B1 knockout mice showed 
significant decreases in α-T levels in various tissues including 
liver, spleen and kidney. SR-B1 may be responsible for tissue 
α-T levels by regulating α-T influx into cells (Mardones et al., 
2002). These results suggest that the levels of lipoproteins and 
SR-B1 maybe responsible for regulation of plasma and tissue 
α-T concentrations. 
Variability of α-T levels shown in the same tissues treated with 
normal diets maybe due to the dietary form (natural or synthetic) 
of  α-T, the amount of dietary fat in diets and/or the duration 
of dietary treatments. With α-T supplementation plasma and 
tissue levels of α-T in α-TTP
-/- mice on the diets containing 
different levels of α-T showed considerable variability suggesting 
that these differences are likely to be tissue specific. 
Since there are still limitations to evaluate the relationship 
between dietary α-T levels and tissue α-T concentrations, and 
the roles of α-TTP in different tissues further studies in this 
animal model are recommended. 
Conclusions
α-TTP
-/- mice are characterized by abnormalities that can be 
reversed, prevented or attenuated by high α-T supplementation. 
Additionally, specific genes sensitive to α-TTP were discussed. 
Plasma and tissue α-T levels in α-TTP
-/- mice reflected dietary 
α-T levels in tissue specific manner.
These results emphasize the benefit of α-T supplementation 
in vitamin E deficiency caused by genetic defects of α-TTP in 
humans (AVED). However, α-TTP expression in various tissues 
leads to questions such as tissue specific α-T requirements and 
other α-TTP functions beyond binding and transferring α-T in 
cells. α-TTP
-/- mice combined with dietary vitamin E deficiency 
appear to present an ideal model for investigating the specific 
roles of α-T and even other vitamin E analogues in different 
tissues. Furthermore, α-TTP
-/- mice would be a good genetic 
model to identify genes associated with α-T in various diseases 
and for dissociating antioxidant functions of α-T from its 
non-antioxidant functions. 
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